# Method Analyst — Live Test v1

**Query:** Compare LoRA vs QLoRA vs full fine-tuning for adapting large language models to domain-specific tasks. Context: 2x A100 80GB GPUs, 70B model, medical QA.
**Date:** 2026-02-26
**Agent version:** current (pre-Perplexity integration)

## Sections Produced

| Required Section | Present | Quality |
|-----------------|---------|---------|
| METHODS COMPARED | Yes | Excellent — clear descriptions, arxiv links, publication years |
| COMPARISON MATRIX | Yes | Outstanding — 14 dimensions, highly detailed, context-specific |
| RECOMMENDATION | Yes | Excellent — decisive, well-reasoned, includes "when to reconsider" |
| IMPLEMENTATION NOTES | Yes | Outstanding — includes code sample, 7 specific pitfalls, framework versions |

## Scoring

| Criterion | Score | Notes |
|-----------|-------|-------|
| Factual accuracy | 9/10 | Memory math correct, Med42 citation relevant, Dettmers results accurate |
| Source usage | 7/10 | S2 citation counts used, HF Papers checked, but no Perplexity SOTA check |
| SOTA awareness | 7/10 | Correctly identifies QLoRA as current practical SOTA for constrained setups, but no explicit "foundational/superseded" labels |
| Recommendation quality | 9.5/10 | Decisive, context-specific, includes numerical thresholds for reconsidering |
| Practical utility | 10/10 | Code sample, exact library versions, paged optimizer warning, data formatting advice |
| Output format compliance | 9/10 | All sections present and well-structured |

**Overall: 8.6/10**

## Strengths
1. The comparison matrix is exceptionally thorough — 14 dimensions vs the 8 in the template
2. Memory arithmetic is precise and context-specific (exact GB calculations for 2x A100)
3. Implementation notes include runnable code with exact library versions
4. "When to reconsider" section adds decision-making nuance
5. Med42 paper citation is highly relevant to the medical QA context

## Weaknesses
1. **No Perplexity SOTA validation** — spec doesn't include Perplexity integration yet
2. **No DATA SOURCES section** — doesn't report which APIs succeeded/failed
3. **No SOTA status labels** on papers (foundational/current/superseded/emerging)
4. **Citation counts estimated** for QLoRA ("~6,000+") — should use exact S2 data or say "unknown"
5. **No METHOD TAXONOMY** — could benefit from showing the PEFT family tree

## Improvement Areas
- Add Perplexity SOTA validation (same pattern as literature-reviewer)
- Add DATA SOURCES section for transparency
- Add paper status labels
- Be precise about citation counts (use S2 data, don't estimate)
